Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px
Document › Details

Transgene S.A.. (7/2/19). "Press Release: Success of Transgene’s €48.7 Million Rights Issue [This document must not be distributed, directly or indirectly, in the United States of America, Australia, Canada or Japan]". Strasbourg.

Organisations Organisation Transgene S.A. (Euronext: TNG)
  Group Mérieux (Group)
  Organisation 2 Bryan, Garnier & Co., Ltd.
Products Product Invir.IO™ oncolytic virus technology platform
  Product 2 investment banking
Index term Index term Transgene–SEVERAL: investment, 201906–201907 capital increase €48.7m w preferential subscription rights 20.8m shares at €2.34/share
Person Person Archinard, Philippe (Transgene 200512 CEO)
     


   
Record changed: 2020-01-05

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px

More documents for Mérieux (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px




» top